Are These Stocks Good In The Medium Term? Cocrystal Pharma Inc (COCP), Cannabiz Mobile Inc (LGBI) and PharmaCyte Biotech Inc (PMCB)

Posted by Saimoon April 6, 2015 0 Comment 957 views


New York, NY – GDP INSIDER  –  04/06/2015.

This article discusses three companies: Cocrystal Pharma Inc (OTCBB:COCP), Cannabiz Mobile Inc (OTCMKTS:LGBI) and PharmaCyte Biotech Inc (OTCMKTS:PMCB)

Cocrystal Pharma Inc (OTCBB:COCP) fell back on Thursday from its 52 week high of $1.53 to close down 2.04% or $0.03 at $1.44 on relatively light trading of 0.994 million shares, compared to its three month average trading volume of 1.413 million. The novel medication developer focused on human viral diseases has been having a very strong year so far, with the stock up 242.86%, but is trading uncertainly at the moment, as its RSI is at 76.80 making investors nervous. With its direction uncertain at this time, it is best to hold or profit-take at this price.

Is Cocrystal Pharma Inc Going To Keep Climbing? Take A Look At The Technical Indicators With Our Free COCP Analysis.

Cannabiz Mobile Inc (OTCMKTS:LGBI) retreated again on Thursday after making strong gains earlier in the week to close down 12.50% or $0.0003 at $0.0021 on heavy trading of 88.308 million, compared to its three month average trading volume of 26.852 million. The mobile and media marketer for medical marijuana is not doing especially well at the moment, with quarterly revenue down 30.9% year on year and diluted EPS of -$0.22. Even with renewed investor interest in this sector, it is better to sell as it is not an attractive buy for now.

Does Cannabiz Mobile Inc Have Long Term Potential? Read Our Free LGBI Analysis For More Details.

PharmaCyte Biotech Inc (OTCMKTS:PMCB) compounded its recent gains by adding another 2.32% or $0.0035 to close at $0.1545, with more than 3.240 million shares changing hands, compared to its three month average trading volume of 2.565 million. The international biotech live encapsulated cell provider for diabetes treatments is attracting investor interest after the recent flurry of mergers and acquisitions in the sector. With a lot of major biotech companies patents due to expire in the next year, innovative firms like PharmaCyte Biotech Inc are potential targets, making it a hold and potential buy.

Is Pharmacyte Biotech Inc Undervalued? Click Here For Free PMCB Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment